Nov Inc Stock Alpha and Beta Analysis

NOV Stock  USD 14.30  0.31  2.22%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as NOV Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in NOV over a specified time horizon. Remember, high NOV's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to NOV's market risk premium analysis include:
Beta
0.95
Alpha
(0.01)
Risk
2.46
Sharpe Ratio
(0.01)
Expected Return
(0.03)
Please note that although NOV alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, NOV did 0.01  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of NOV Inc stock's relative risk over its benchmark. NOV Inc has a beta of 0.95  . NOV returns are very sensitive to returns on the market. As the market goes up or down, NOV is expected to follow. Book Value Per Share is likely to climb to 17.34 in 2025, whereas Tangible Book Value Per Share is likely to drop 7.13 in 2025.

NOV Quarterly Cash And Equivalents

513 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out NOV Backtesting, NOV Valuation, NOV Correlation, NOV Hype Analysis, NOV Volatility, NOV History and analyze NOV Performance.

NOV Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. NOV market risk premium is the additional return an investor will receive from holding NOV long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in NOV. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate NOV's performance over market.
α-0.0097   β0.95

NOV expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of NOV's Buy-and-hold return. Our buy-and-hold chart shows how NOV performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

NOV Market Price Analysis

Market price analysis indicators help investors to evaluate how NOV stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NOV shares will generate the highest return on investment. By understating and applying NOV stock market price indicators, traders can identify NOV position entry and exit signals to maximize returns.

NOV Return and Market Media

The median price of NOV for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 14.88 with a coefficient of variation of 3.75. The daily time series for the period is distributed with a sample standard deviation of 0.56, arithmetic mean of 14.89, and mean deviation of 0.43. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Insider Trading
12/13/2024
2
Novatti Group Insider Ups Holding By 22 percent During Year
12/31/2024
3
NOV Reports Fourth Quarter and Full-Year 2024 Earnings
02/04/2025
4
Disposition of 4773 shares by Christy Novak of NOV at 15.48 subject to Rule 16b-3
02/06/2025
5
Disposition of 5293 shares by Christy Novak of NOV at 15.54 subject to Rule 16b-3
02/14/2025
6
Acquisition by Clay Williams of 134731 shares of NOV at 15.28 subject to Rule 16b-3
02/19/2025
7
Uncommon Surge in Options Trading Activity for NOV
02/20/2025
8
Disposition of 13563 shares by Clay Williams of NOV at 15.11 subject to Rule 16b-3
02/21/2025
9
NOVs SWOT analysis energy equipment stock faces mixed outlook - Investing.com
02/26/2025
10
Disposition of 2184 shares by Joseph Rovig of NOV at 15.54 subject to Rule 16b-3
02/28/2025
11
First Eagle Investments Strategic Acquisition of NOV Inc Shares
03/05/2025
12
Do Its Financials Have Any Role To Play In Driving NOV Inc.s Stock Up Recently
03/10/2025
13
Is A Recession Coming in 2025 Where to Invest Now
03/13/2025

About NOV Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including NOV or other stocks. Alpha measures the amount that position in NOV Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 2025 (projected)
Dividend Yield0.0099120.01890.0153
Price To Sales Ratio0.930.650.61

NOV Upcoming Company Events

As portrayed in its financial statements, the presentation of NOV's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NOV's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of NOV's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of NOV. Please utilize our Beneish M Score to check the likelihood of NOV's management manipulating its earnings.
1st of February 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
1st of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with NOV

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for NOV Stock Analysis

When running NOV's price analysis, check to measure NOV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NOV is operating at the current time. Most of NOV's value examination focuses on studying past and present price action to predict the probability of NOV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NOV's price. Additionally, you may evaluate how the addition of NOV to your portfolios can decrease your overall portfolio volatility.